The estimated Net Worth of Thomas Tu is at least $22.4 Millón dollars as of 16 July 2024. Dr Tu owns over 3,480 units of Inari Medical stock worth over $13,961,649 and over the last 4 years he sold NARI stock worth over $7,516,320. In addition, he makes $904,218 as Chief Medical Officer at Inari Medical.
Dr has made over 31 trades of the Inari Medical stock since 2020, according to the Form 4 filled with the SEC. Most recently he sold 3,480 units of NARI stock worth $191,957 on 16 July 2024.
The largest trade he's ever made was exercising 292,584 units of Inari Medical stock on 12 March 2023 worth over $13,186,761. On average, Dr trades about 12,122 units every 31 days since 2020. As of 16 July 2024 he still owns at least 309,777 units of Inari Medical stock.
You can see the complete history of Dr Tu stock trades at the bottom of the page.
Dr. Thomas M. Tu M.D. is the Chief Medical Officer at Inari Medical.
As the Chief Medical Officer of Inari Medical, the total compensation of Dr D at Inari Medical is $904,218. There are 1 executives at Inari Medical getting paid more, with William H. Hoffman having the highest compensation of $1,128,458.
Dr D is 48, he's been the Chief Medical Officer of Inari Medical since . There are 3 older and no younger executives at Inari Medical. The oldest executive at Inari Medical, Inc. is Mitchell C. Hill, 62, who is the Chief Financial Officer.
Thomas's mailing address filed with the SEC is C/O INARI MEDICAL, INC., 6001 OAK CANYON, IRVINE, CA, 92618.
Over the last 4 years, insiders at Inari Medical have traded over $519,947,508 worth of Inari Medical stock and bought 1,100,480 units worth $22,863,324 . The most active insiders traders include Gilde Healthcare Iv U.A.Gil..., William Hoffman y Andrew Hykes. On average, Inari Medical executives and independent directors trade stock every 7 days with the average trade being worth of $1,998,809. The most recent stock trade was executed by Andrew Hykes on 20 August 2024, trading 3,000 units of NARI stock currently worth $150,000.
Inari Medical, Inc., a medical device company, develops, manufactures, markets, and sells devices for the interventional treatment of venous diseases in the United States. The company provides ClotTriever, a mechanical thrombectomy system, which is designed to core, capture, and remove large clots from large vessels, as well as for treatment of deep vein thrombosis; and FlowTriever, a large bore catheter-based aspiration and mechanical thrombectomy system, for treatment of pulmonary embolism. It also offers FlowSaver; FlowStasis, a large bore suture retention device designed to address various aspects of venous access site; and FlowTriever 2, a new disk shape designed to capture and remove wall adherent clot and shorten treatment. The company was formerly known as Inceptus Newco1 Inc. and changed its name to Inari Medical, Inc. in September 2013. Inari Medical, Inc. was incorporated in 2011 and is headquartered in Irvine, California.
Inari Medical executives and other stock owners filed with the SEC include: